Uncategorized

Traded on the Toronto Stock Exchange (TSX), under the symbol PMN.TO, and on the OTCQB under the symbol ARFXF, ProMIS Neurosciences, Inc., is a development stage biotech company that discovers and develops precision therapeutics for treatment of neurodegenerative diseases, in particular Alzheimer’s disease (AD) and amyotrophic lateral sclerosis (ALS).

Traded on the Toronto Stock Exchange (TSX), under the symbol PMN.TO, and on the OTCQB under the symbol ARFXF